Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2002

Sellers WR, Loda M. The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer? Cancer Cell. 2002;2(5):349-50.

Winter WE, Kucera PR, Rodgers W, McBroom JW, Olsen C, G Maxwell L. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol. 2002;100(4):671-6.

Hanash SM, Bobek MP, Rickman DS, Williams T, Rouillard JM, Kuick R, et al. Integrating cancer genomics and proteomics in the post-genome era. Proteomics. 2002;2(1):69-75.

Chiu A, Pan L, Li Z, Ely S, Chadburn A, Knowles DM. DNA polymerase mu gene expression in B-cell non-Hodgkin's lymphomas: an analysis utilizing in situ hybridization. Am J Pathol. 2002;161(4):1349-55.

Shaw JA, Udokang K, Mosquera J-, Chauhan H, J Jones L, Walker RA. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. J Pathol. 2002;198(4):450-7.

Ponting CP, Ito T, Moscat J, Diaz-Meco MT, Inagaki F, Sumimoto H. OPR, PC and AID: all in the PB1 family. Trends Biochem Sci. 2002;27(1):10.

Korkmaz KS, Elbi C, Korkmaz CG, Loda M, Hager GL, Saatcioglu F. Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem. 2002;277(39):36689-96.

Magro CM, Deng A, Pope-Harman A, W Waldman J, A Collins B, Adams PW, et al. Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. Transplantation. 2002;74(9):1273-80.

Tourigny MR, Ursini-Siegel J, Lee H, Toellner K-, Cunningham AF, Franklin DS, et al. CDK inhibitor p18(INK4c) is required for the generation of functional plasma cells. Immunity. 2002;17(2):179-89.

Zamò A, Chiarle R, Piva R, Howes J, Fan Y, Chilosi M, et al. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene. 2002;21(7):1038-47.